Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 6, 1999, Pages 515-525

  Dheur, Sonia ^a   Dias, Nathalie ^a   Van Aerschot, Arthur ^b   Herdewijn, Piet ^b   Bettinger, Thierry ^c   Rémy, Jean Serge ^c   Hélène, Claude ^a   Saison Behmoaras, E Tula ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPID; LIPOFECTIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PHOSPHODIESTERASE; POLYETHYLENEIMINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; ONCOGENE H RAS; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0033427317     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.515     Document Type: Article

References (26)

1. ABDALLAH, B., HASSAN, A., BENOIST, C., GOULA, D., BEHR, J.P., and DEMENEIX, B.A. (1996). A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther. 7, 1947-1954.
2. AKHTAR, S., and AGRAWAL, S. (1997). In vivo studies with antisense oligonucleotides. Trends Pharmacol. Sci. 18, 12-18.
3. BENNETT, C.F., CHIANG, M.Y., CHAN, H., SHOEMAKER, J.E., and MIRABELLI, C.K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023-1033.
4. BENNETT, C.F., CONDON T.P., GRIMM, S., CHAN, H., and CHIANG, M.Y. (1994). Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152, 3530-3540.
5. BOUSSIF, O., LEZOUALC'H, F., ZANTA, M.A., MERGNY, M.D., SCHERMAN, D., DEMENEIX, B., and BEHR, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297-7301.
6. BOUSSIF, O., ZANTA, M.A., and BEHR, J.P. (1996). Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3, 1074-1080.
7. BRANCH, A.D. (1998). A good antisense molecule is hard to find. TIBS 23, 45-50.
8. BROWN, D.A., KANG, S.H., GRYAZNOV, S.M., DEDIONISIO, L., HEIDENREICH, O., SULLIVAN, S., XU, X., and NERENBERG, M.I. (1994). Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801-26805.
9. CHIANG, M.Y., CHAN, H., ZOUNES, M.A., FREIER, S.M., LIMA, W.F., and BENNETT, C.F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
10. DUROUX, I., GODARD, G., BOIDOT-FORGET, M., SCHWAB, G., HÉLÈNE, C., and SAISON-BEHMOARAS, T. (1995). Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Nucleic Acids Res. 23, 3411-3418.
11. GEWIRTZ, A.M., SOKOL, D.L., and RATAJCZAK, M.Z. (1998). Nucleic acid therapeutics: State of the art and future prospects. Blood 92, 712-736.
12. HEIMER, G.V., and TAYLOR, C.E. (1974). Improved mountant for immunofluorescence preparations. J. Clin. Pathol. 27, 254-256.
13. KREN, B.T., BANDYOPADHYAY, P., and STEER, C.J. (1998). In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nature Med. 4, 285-290.
14. 2+ channel structure and function with antisense oligonucleotides. Mol. Cell Neurosci. 7, 239-246.
15. LEBEAU, J., LE CHALONY, C., PROSPERI, M.T., and GOUBIN, G. (1991). Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by EJ/T24 Harvey-ros oncogene. Oncogene 6, 1125-1132.
16. MONIA, B.P., JOHNSTON, J.F., ECKER, D.J., ZOUNES, M.A., LIMA, W.F., and FREIER, S.M. (1992). Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267, 19954-19962.
17. MONIA, B.P., JOHNSTON, J.F., GEIGER, T., MULLER, M., and FABBRO, D. (1996a). Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature Med. 2, 668-675.
18. MONIA, B.P., JOHNSTON, J.F., SASMOR, M., and CUMMINS, L.L. (1996b). Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J. Biol. Chem. 271, 74533-74540
19. PEREZ, J.R., LI, Y., STEIN, C.A., MAJUMDER, S., VAN OORSCHOT, A., and NARAYANAN, R. (1994). Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91, 5957-5961.
20. POLLARD, H., RÉMY, J.S., LOUSSOUARN, G., DEMOLOMBE, S., BEHR, J.P., and ESCANDE, D. (1998). Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273, 7507-7511.
21. SCHWAB, G., CHAVANY, C., DUROUX, I., GOUBIN, G., LEBEAU, J., HÉLÈNE, C., and SAISON-BEHMOARAS, T. (1994). Antisense oligonucleotides absorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc. Natl. Acad. Sci. USA 91, 10460-10464.
22. SNYDER, S.L., and SOBOCINSKI, P.Z. (1975). An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem. 64, 284-288.
23. STEIN, C.A. (1995). Does antisense exist? Nature Med. 1, 1119-1121.
24. VAN AERSCHOT, A., SAISON-BEHMOARAS, T., ROZENSKI, J., HENDRIX, C., SCHEPERS, G., VERHOEVEN, G., and HERDEWIGN, P. (1995). Conjugation of oligonucleotides to 3′-polar moieties. Bull. Soc. Chim. Belges 104, 717-720.
25. ZELPHATI, O., IMBACH, J.L., SIGNORET, N., ZON, G., RAYNER, B., and LESERMAN, L. (1994). Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Nucleic Acids Res. 22, 4307-4314.
26. ZELPHATI, O., and SZOKA, F.C. (1996). Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA 93, 11493-11498.